News

Johnson & Johnson Seeks FDA Authorization For COVID-19 Vaccine Booster Shots

On Tuesday, Johnson & Johnson petitioned the U.S. Food and Drug Administration (FDA) to authorize a booster shot of its COVID-19 vaccine.

J&J had previously revealed an internal study Monday that showed a second shot administered two months after the first shot improved immunity against symptomatic moderate to severe symptoms to COVID to 94 percent.

“A booster of our COVID-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent,” said Mathai Mammen, who’s in charge of the global R&D division at J&J’s Janssen. “At the same time, we continue to recognize that a single-shot COVID-19 vaccine that provides strong and long-lasting protection remains a crucial component to vaccinating the global population.”

As the pharmaceutical company submitted its petition, the FDA’s independent vaccine advisory committee is set to meet on Oct. 15 to discuss whether to recommend the booster shot from J&J to the federal agency.

Subscribe to our free weekly newsletter!

A week of political news in your in-box.
We find the news you need to know, so you don't have to.

J&J’s single-dose vaccine has experienced several problems since FDA gave the Emergency Use Authorization to the company.

In April, the J&J vaccine was paused over rare blood clotting symptoms shown by dozens of women who got the single shot. The production was also disrupted for months due to the mistakes made by the Baltimore manufacturing plant.

On Tuesday, the Public Health Insider reported that another woman in her late 30s died from blood clotting symptoms last month after she was given a J&J shot.

“We at Public Health are saddened by this loss and offer condolences to the woman’s family and loved ones. The resident received her vaccination on August 26, 2021 and died on September 7, 2021. Her cause of death was determined to be thrombosis with thrombocytopenia syndrome (TTS), a condition that has been identified as a rare but potentially serious adverse event in people who received the J&J vaccine. The diagnosis was confirmed by the CDC’s Clinical Immunization Safety Assessment Project,” the statement read.

Dongyoon Shin

Share
Published by
Dongyoon Shin

Recent Posts

After Federal Court Rules Against Trump’s Tariffs, President’s Trade Policy Becomes Even More Chaotic

A panel of federal judges has struck down President Donald Trump's tariffs imposed on dozens…

6 hours ago

Egged On By Right-Wing Conspiracy Theorists, Trump Wants To Visit Fort Knox To Make Sure Gold Is Still There

President Donald Trump wants to personally visit Fort Knox, which holds the United States Bullion…

7 hours ago

Trump’s ‘One Big Beautiful’ Budget Bill Shifts Resources From Nation’s Poorest To Weathiest, CBO Says

Despite two Republicans crossing the aisle to side with every Democrat voting no, President Donald…

8 hours ago

VIDEO: Sen. Joni Ernst Justifies GOP Cuts To Medicare At Iowa Town Hall: ‘Well, We All Are Going to Die’

https://www.youtube.com/shorts/XoYMPUgCLx4 During a town hall on May 30, Iowa Sen. Joni Ernst (R) responded to…

13 hours ago

HHS Sec. Robert F. Kennedy Jr. Says He’ll Ban Agency Scientists From Publishing Findings In Prestigious Medical Journals

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. threatened to prohibit government scientists…

1 day ago

As He Exits Administration, Elon Musk Criticizes Trump Budget Bill For Exploding Deficit

Elon Musk took to social media to criticize the Republican budget bill that recently passed…

1 day ago